About: Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 2021 and is based in Subiaco, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.41 (+7.89%)
ID1 ASX Identifai Genetics Limited
Identifai Genetics Limited share price
ID1 price activity
Last Price
$0.410
Change (24hr)
0.03 AUD (7.89%)
Volume
227.60K
Volume (4w avg)
-
Open
$0.40
Day Range
$0.40 - $0.42
Previous Close
$0.38
Last Trade
20 Nov, 12:45 am GMT+0
Delayed
20 Nov, 12:45 am GMT+0
ID1 price performance
Delayed
20 Nov, 12:45 am GMT+0
ID1 details
ID1 Market Signals